We propose to develop, optimize, and market a novel method to deliver DNA to eukaryotic cells. This method would represent a significant advancement in gene delivery technology and have immediate application in basic research laboratories and for gene therapy strategies.
Success in the proposed endeavor would have significant commercial potential, both in the area of gene therapy and in basic molecular biology research.
